Citichem India Limited is a diversified industrial enterprise headquartered in **Mumbai, Maharashtra**. Originally incorporated in **1992**, the company has recently undergone a significant transformation, transitioning from a private entity to a publicly listed corporation on the **BSE SME Platform**. While its historical core competency lies in the chemical trade, the company is currently executing a multi-sectoral expansion strategy into food processing, waste management, and digital services. --- ### **Core Business Verticals & Product Portfolio** The company operates through a single reporting segment that integrates its legacy chemical operations with its newly established food division. #### **1. Chemical Division (Manufacturing & Trading)** Citichem maintains a robust presence in the **Organic, Inorganic, Specialty, and Food Chemical** markets. Its primary product lines include: * **Alkali Products:** Caustic Soda Flakes, Caustic Soda Lye, and Soda Ash Light. * **Industrial Acids:** Acetic Acid. * **Food-Grade Chemicals:** Mono Sodium Glutamate (MSG). * **Pharmaceutical Support:** The company holds **Pharma License No. MH - TZS - 335245**, allowing it to serve regulated industries. #### **2. Food Division (Strategic Expansion)** A primary growth driver for the company is its entry into the **Ready-to-Eat (RTE)** and **Ready-to-Cook (RTC)** segments. * **Product Range:** Snacks, frozen foods, instant meals, baked goods, confectionery, dairy products, spices, and dehydrated vegetables. * **Target Markets:** Direct-to-consumer channels, food processing units, beverage industries, and large-scale confectionery manufacturers. #### **3. Ancillary & Emerging Business Objects** To diversify revenue streams, the company has expanded its constitutional objects to include: * **Plastic Waste Management:** Collection, segregation, and reprocessing of waste plastic. * **IT & Digital Services:** Software development, e-commerce portal management, and technical consultancy. * **Advertising:** Full-service publicity agency operations and market research. --- ### **Capital Structure & Listing Information** Citichem successfully completed its **Initial Public Offer (IPO)** in **January 2025**, listing on the **BSE SME Platform**. | Metric / Identifier | Details | | :--- | :--- | | **BSE Scrip Code** | **544324** | | **ISIN** | **INE0A8401016** | | **CIN** | **U24100MH1992PLC065975** | | **Authorized Share Capital** | **INR 12.5 Crore** (Increased from **INR 7.5 Crore** in Sept 2025) | | **Paid-up Equity Capital** | **INR 6.80 Crore** (6,800,000 shares at **INR 10** face value) | | **IPO Issue Price** | **INR 70** per share (including **INR 60** premium) | | **Market Maker** | **Aftertrade Broking Private Limited** | **Shareholding Pattern Evolution:** Following a proposed (though later adjusted) preferential issue, the **Promoter/Promoter Group** holding is projected to shift from **61.21%** to **73.59%**, with the **Public Holding** adjusting from **38.79%** to **26.41%**. --- ### **Strategic Growth & Infrastructure Roadmap** The company is pivoting toward a vertically integrated model to support its expanded Memorandum of Association (MoA). * **Infrastructure Investment:** Plans are underway to establish **Cold storage units**, **Logistics hubs**, and **Food testing laboratories** to secure the supply chain for the RTE/RTC segments. * **R&D and Compliance:** The company is setting up dedicated **Research and Development centers** to ensure products meet international food safety standards and **Central License No. 11519018000620** requirements. * **Inorganic Growth Mandate:** The updated MoA permits **Strategic Alliances, Joint Ventures**, and the acquisition of businesses or trademarks to accelerate market entry. * **Technical Collaborations:** Citichem is actively seeking agreements with **Indian and foreign corporations** for financial and technical "know-how" participation in new manufacturing projects. --- ### **Financial Management & Fund Utilization** The company has demonstrated a disciplined approach to capital deployment, specifically regarding its **January 2025 IPO** proceeds. **IPO Fund Utilization:** * **Capital Expenditure:** Acquisition of **Property** for operational expansion. * **Logistics:** Purchase of **Transportation Vehicles** and related accessories. * **Corporate Liquidity:** General corporate purposes and issue-related expenses. **Recent Capital Adjustments:** In **November 2025**, the company proposed a preferential issue of **4,700,000 Convertible Warrants** at **INR 29** per warrant to raise **INR 13.63 Crore**. However, in **January 2026**, the company **withdrew** this specific fund-raising plan, citing **adverse market conditions**, volatility, and the lack of in-principle approval from the BSE. The management is currently exploring **alternative fund-raising options** to meet its working capital and Capex requirements. --- ### **Risk Profile & Internal Controls** Citichem operates under a professional governance framework designed to mitigate the inherent risks of the chemical and food sectors. * **Market & Regulatory Risks:** The company faces intense competition and potential shifts in **Government Policies**. It mitigates these through brand strengthening and rigorous compliance with the **Companies Act, 2013**. * **Financial Confirmations:** Currently, balances for trade payables, receivables, and loans are **unsecured** and subject to party confirmations. * **MSME Compliance:** Information regarding the registration status of suppliers under the **MSMED Act, 2006** is currently being updated; potential interest liabilities are presently unascertained. * **Liquidity Management:** The company successfully navigated a potential disruption in market-making services in mid-2025, ensuring continuous quote provision on the BSE platform. **Internal Oversight Mechanism:** | Component | Responsibility | | :--- | :--- | | **Internal Audit** | Periodic verification that all transactions are **correctly authorized and reported**. | | **Audit Committee** | Monitors the **effectiveness of internal control systems** and reviews audit findings. | | **Governance** | Ensures timely compilation of **financial statements** and transparent investor communication. |